Aydah AlAwadhi, Consultant Medical Oncologist and Division Chair of Hematology and Oncology Department at Sheikh Shakbout Medical City, Abu Dhabi, shared a post on LinkedIn:
“As we approach the end of the year, I compiled a list of all FDA oncology approvals in 2025, both new drugs and new indications for existing therapies.
The list is long, and it keeps growing.
An exciting time in oncology, with real impact for our patients, and even more to come.
Let me know if I missed any.”
More posts featuring Aydah AlAwadhi.
